223 related articles for article (PubMed ID: 18646354)
21. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey.
Haapamäki J; Turunen U; Roine RP; Färkkilä MA; Arkkila PE
Scand J Gastroenterol; 2008; 43(7):821-30. PubMed ID: 18584521
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study.
De Angelis R; Salaffi F; Grassi W
Scand J Rheumatol; 2007; 36(1):14-21. PubMed ID: 17454930
[TBL] [Abstract][Full Text] [Related]
23. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study.
Ott C; Obermeier F; Thieler S; Kemptner D; Bauer A; Schölmerich J; Rogler G; Timmer A
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):917-23. PubMed ID: 18794607
[TBL] [Abstract][Full Text] [Related]
24. Risk of arterial thrombotic events in inflammatory bowel disease.
Ha C; Magowan S; Accortt NA; Chen J; Stone CD
Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
[TBL] [Abstract][Full Text] [Related]
25. [Magnetic resonance imaging in ankylosing spondylitis (Marie-Struempell-Bechterew disease)].
Bollow M
Rofo; 2002 Dec; 174(12):1489-99. PubMed ID: 12471519
[TBL] [Abstract][Full Text] [Related]
26. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
[TBL] [Abstract][Full Text] [Related]
27. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients.
Nguyen GC; Sam J
Am J Gastroenterol; 2008 Sep; 103(9):2272-80. PubMed ID: 18684186
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
29. Medication profiles of patients in the University of Puerto Rico inflammatory bowel disease registry.
Meléndez JD; Larregui Y; Vázquez JM; Carlo VL; Torres EA
P R Health Sci J; 2011 Mar; 30(1):3-8. PubMed ID: 21449490
[TBL] [Abstract][Full Text] [Related]
30. The joint-gut axis in inflammatory bowel diseases.
Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH
J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
32. The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel Disease.
Kelly OB; Li N; Smith M; Chan J; Inman RD; Silverberg MS
Inflamm Bowel Dis; 2019 May; 25(6):1066-1071. PubMed ID: 30428061
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
34. Differences in prevalence of inflammatory bowel disease in Puerto Rico between commercial and government-sponsored managed health care insured individuals.
Vendrell R; Venegas HL; Pérez CM; Morell C; Roman RV; Torres EA
Bol Asoc Med P R; 2013; 105(2):15-9. PubMed ID: 23882984
[TBL] [Abstract][Full Text] [Related]
35. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
Subramaniam K; Tymms K; Shadbolt B; Pavli P
Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
[TBL] [Abstract][Full Text] [Related]
37. Profile of the inflammatory bowel disease patient with depressive disorders.
Acosta-Ramírez D; Pagán-Ocasio V; Torres EA; Rodríguez M; Caro O
P R Health Sci J; 2001 Sep; 20(3):215-20. PubMed ID: 11776721
[TBL] [Abstract][Full Text] [Related]
38. Subclinical sacroiliitis in inflammatory bowel disease: a clinical and follow-up study.
Queiro R; Maiz O; Intxausti J; de Dios JR; Belzunegui J; González C; Figueroa M
Clin Rheumatol; 2000; 19(6):445-9. PubMed ID: 11147753
[TBL] [Abstract][Full Text] [Related]
39. An assessment of back pain and the prevalence of sacroiliitis in sarcoidosis.
Erb N; Cushley MJ; Kassimos DG; Shave RM; Kitas GD
Chest; 2005 Jan; 127(1):192-6. PubMed ID: 15653983
[TBL] [Abstract][Full Text] [Related]
40. [Joint involvement in chronic inflammatory bowel disease--current diagnostics and treatment options].
Becker H; Gaubitz M; Domschke W; Kucharzik T
Z Gastroenterol; 2006 Jun; 44(6):497-502. PubMed ID: 16773516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
